Latest Post
From Diagnosis to Remission: My MG Story
I woke up on my birthday – it was January 1993 – and I was seeing double.
LATEST FROM THE MGFA INSIDER BLOG
When Patients Become Partners in Research: Elizabeth’s Story
At just 12 years old, Elizabeth Madole is already helping shape the future of myasthenia gravis care. She lives with AChR antibody–positive generalized MG, a rare autoimmune disease that causes muscle weakness and can affect breathing, swallowing, and mobility. From a young age, her symptoms were severe, including life-threatening episodes. She has experienced what many […]
A New Era for the MG Patient Registry: Empowering Patients, Advancing Research
MGFA is proud to announce the next stage in the evolution of the MG Patient Registry: the Vitaccess Real MG Registry.
Targeting B cells may help people with MuSK Myasthenia Gravis
“For me, precision medicine has always been the holy
grail of what we’re trying to
achieve.”
Researcher Investigates MG Mechanisms of Disease Thanks to Donor and MGFA Support
As a child in Iran, Dr. Fatemeh Khani Habibabadi was always
interested in the world around her. Now her research in autoimmune neurological
disorders is making a difference for people with MG.
Pediatric MG: Listen to This Podcast Episode
MGFA’s Meridith O’Connor talks with Dr.
Jonathan Strober, director of the Neuromuscular Clinic at Benioff Children’s
Hospital.
Can Car T-Cell Therapy Effectively Treat Myasthenia Gravis?
Danny DeBerry and his CAR T-Cell Therapy story.
MGFA Partnership with argenx Helps Bring New Treatment Option to MG Patients
The story of argenx and MGFA’s collaboration to bring
about a new MG treatment.
New Book by a Leading Doctor Will Help You Cope with Myasthenia
All proceeds from Coping with Myasthania
Gravis book will benefit MGFA
Rituximab: Why B cell reduction therapy doesn’t work for all MG patients
Kevin O’Connor, PhD discusses why some MuSK MG
patients relapse after Rituximab.
Thymectomy and MG
Dr. Kevin O’Connor discusses Thymectomy and why
symptoms persist after the procedure.